Page last updated: 2024-10-30

lamotrigine and Cirrhosis, Liver

lamotrigine has been researched along with Cirrhosis, Liver in 3 studies

Research Excerpts

ExcerptRelevanceReference
" To test whether glucuronidation reactions supported by UDP-glucuronosyltransferases are differentially affected in such conditions, we investigated the in vitro glucuronidation of four selected drugs and xenobiotics (zidovudine, oxazepam, lamotrigine, and umbelliferone) by using microsomes from human healthy and unhealthy (cirrhosis, hepatitis) livers as enzyme sources."3.70Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers. ( Bourdon, O; Demirdjian, S; Furlan, V; Magdalou, J; Taburet, AM, 1999)
" Plasma half-life mean ratios (90% confidence interval) in these two patient groups to healthy subjects were, respectively, 204% (149%, 278%) and 287% (202%, 408%)."2.70Influence of cirrhosis on lamotrigine pharmacokinetics. ( Altman, C; Bidault, R; Boige, V; Castelnau, C; Chen, C; de Bony, F; Garret, C; Laurent-Puig, P; Mamet, JP; Marcellin, P; Rolan, P; Trinchet, JC, 2001)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aebischer, B1
Elsig, S1
Taeymans, J1
Pomp, S1
Kuhness, D1
Barcaro, G1
Sementa, L1
Mankad, V1
Fortunelli, A1
Sterrer, M1
Netzer, FP1
Surnev, S1
Schmieder, AH1
Caruthers, SD1
Keupp, J1
Wickline, SA1
Lanza, GM1
Lowe, J1
Wodarcyk, AJ1
Floyd, KT1
Rastogi, N1
Schultz, EJ1
Swager, SA1
Chadwick, JA1
Tran, T1
Raman, SV1
Janssen, PM1
Rafael-Fortney, JA1
Alcalay, RN1
Levy, OA1
Wolf, P1
Oliva, P1
Zhang, XK1
Waters, CH1
Fahn, S1
Kang, U1
Liong, C1
Ford, B1
Mazzoni, P1
Kuo, S1
Johnson, A1
Xiong, L1
Rouleau, GA1
Chung, W1
Marder, KS1
Gan-Or, Z1
Kamei, K1
Terao, T1
Katayama, Y1
Hatano, K1
Kodama, K1
Shirahama, M1
Sakai, A1
Hirakawa, H1
Mizokami, Y1
Shiotsuki, I1
Ishii, N1
Inoue, Y1
Akboga, MK1
Yayla, C1
Balci, KG1
Ozeke, O1
Maden, O1
Kisacik, H1
Temizhan, A1
Aydogdu, S1
Zhu, J2
Ying, SH1
Feng, MG1
Zhang, XG1
Li, H1
Wang, L1
Hao, YY1
Liang, GD1
Ma, YH1
Yang, GS1
Hu, JH1
Pfeifer, L1
Goertz, RS1
Neurath, MF1
Strobel, D1
Wildner, D1
Lin, JT1
Yang, XN1
Zhong, WZ1
Liao, RQ1
Dong, S1
Nie, Q1
Weng, SX1
Fang, XJ1
Zheng, JY1
Wu, YL1
Řezanka, T1
Kaineder, K1
Mezricky, D1
Řezanka, M1
Bišová, K1
Zachleder, V1
Vítová, M1
Rinker, JA1
Marshall, SA1
Mazzone, CM1
Lowery-Gionta, EG1
Gulati, V1
Pleil, KE1
Kash, TL1
Navarro, M1
Thiele, TE1
Zhang, Y1
Huang, Y1
Jin, Z1
Li, X1
Li, B1
Xu, P1
Huang, P1
Liu, C1
Fokdal, L1
Sturdza, A1
Mazeron, R1
Haie-Meder, C1
Tan, LT1
Gillham, C1
Šegedin, B1
Jürgenliemk-Schultz, I1
Kirisits, C1
Hoskin, P1
Pötter, R1
Lindegaard, JC1
Tanderup, K1
Levin, DE1
Schmitz, AJ1
Hines, SM1
Hines, KJ1
Tucker, MJ1
Brewer, SH1
Fenlon, EE1
Álvarez-Pérez, S1
Blanco, JL1
Peláez, T1
Martínez-Nevado, E1
García, ME1
Puckerin, AA1
Chang, DD1
Subramanyam, P1
Colecraft, HM1
Dogan, H1
Coteli, E1
Karatas, F1
Ceylan, O1
Sahin, MD1
Akdamar, G1
Kryczyk, A1
Żmudzki, P1
Hubicka, U1
Giovannelli, D1
Chung, M1
Staley, J1
Starovoytov, V1
Le Bris, N1
Vetriani, C1
Chen, W1
Wu, L1
Liu, X1
Shen, Y1
Liang, Y1
Tan, H1
Yang, Y1
Liu, Q1
Wang, M1
Liu, L1
Wang, X1
Liu, B1
Liu, GH1
Zhu, YJ1
Wang, JP1
Che, JM1
Chen, QQ1
Chen, Z1
Maucksch, U1
Runge, R1
Wunderlich, G1
Freudenberg, R1
Naumann, A1
Kotzerke, J1
Furlan, V1
Demirdjian, S1
Bourdon, O1
Magdalou, J1
Taburet, AM1
Marcellin, P1
de Bony, F1
Garret, C1
Altman, C1
Boige, V1
Castelnau, C1
Laurent-Puig, P1
Trinchet, JC1
Rolan, P1
Chen, C1
Mamet, JP1
Bidault, R1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
An Open-label, Randomised Pilot Study Comparing the Efficacy, Safety and Tolerability of Raltegravir With Protease Inhibitor-based Therapy in Treatment-naïve, HIV/Hepatitis C Co-infected Injecting Drug Users Receiving Methadone[NCT01105611]Phase 440 participants (Anticipated)Interventional2010-08-31Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for lamotrigine and Cirrhosis, Liver

ArticleYear
    Hand therapy, 2016, Volume: 21, Issue:1

    Topics: AC133 Antigen; Acenaphthenes; Acer; Acrosome Reaction; Adult; Agaricales; Aged; Aged, 80 and over; A

2016

Trials

1 trial available for lamotrigine and Cirrhosis, Liver

ArticleYear
Influence of cirrhosis on lamotrigine pharmacokinetics.
    British journal of clinical pharmacology, 2001, Volume: 51, Issue:5

    Topics: Adult; Anticonvulsants; Female; Humans; Lamotrigine; Liver; Liver Cirrhosis; Male; Middle Aged; Tria

2001

Other Studies

1 other study available for lamotrigine and Cirrhosis, Liver

ArticleYear
Glucuronidation of drugs by hepatic microsomes derived from healthy and cirrhotic human livers.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 289, Issue:2

    Topics: Adolescent; Adult; Aging; Aryl Hydrocarbon Hydroxylases; Biotransformation; Child; Child, Preschool;

1999